2024 Highlights
Montefiore Einstein Urology
Raising the Bar in Research
and Patient Care
At Montefiore Einstein Urology, our continuous expansion and enhancement of urological services have marked another year of significant advancement.
We've launched a new program aimed at improving the lives of individuals with bladder control issues, which includes the comfort-focused option of sedated urodynamics testing. In pediatric urology, we have expanded our programs in robotic and complex reconstructive surgery and are soon to introduce pelvic floor rehabilitation. Our approach to prostate cancer care has evolved with the integration of innovative diagnostic and therapeutic techniques, including transperineal ultrasound-guided biopsies and a focal ablation program utilizing High-Intensity Focused Ultrasound (HIFU) and cryotherapy. These methods are designed to target cancer more precisely while reducing side effects. Complementing our clinical progress, the Montefiore Einstein Urology Research Laboratories have had a remarkable year, securing substantial NIH grant support— a testament to our unwavering commitment to advancing urological health through breakthrough research.
DATA & STATISTICS
2024 by the numbers
36,913
face-to-face visits
2,439
televisits
5,602
office procedures
3,919
OR cases
Innovations and Achievements
Pioneering the future of treatment and care
Montefiore Urology has Joined the Michigan Urological Surgery Improvement Collaborative (MUSIC)
The Michigan Urological Surgery Improvement Collaborative (MUSIC) is a network of clinical sites committed to providing the highest quality possible urologic care. As just the second site outside of Michigan, Montefiore Urology will soon host randomized clinical trials exploring stent omission after ureteroscopy and minimally invasive treatments for prostate cancer.
Kara L. Watts, MD Awarded Co-Chair of the American Urological Association Quality Improvement Summit
Kara L. Watts, MD, Attending Physician, Montefiore Einstein, Professor, Urology, Albert Einstein College of Medicine has been elected as co-chair of the upcoming December AUA Quality Improvement Summit. The title of this year’s summit is “Tackling Telehealth: Improving Quality and Access by Integrating Virtual Care in Urology”.
Pediatric Urology Services Expand to Dobbs Ferry
Our pediatric urology program has expanded our clinical services into Westchester. We now offer surgery at St. John’s Riverside Hospital in Dobbs Ferry. We have increased our clinic staff and now have 2 full-time RNs and 1 full-time LPN to support pediatric urology.
RESEARCH REVIEW
Improving care and outcomes through research
Awards and Recognitions
Amanda North, MD
Awarded the Christina Manthos Mentorship Award from the Society of Women in Urology (SWIU)
Melissa Laudano, MD
Awarded the Davidoff Education Award from Albert Einstein College of Medicine
Kara Watts, MD
Listed as a Castle Connolly top doctor of urology
Franklin Lowe, MD
Listed as a Castle Connolly top doctor of urology
Stanley Boczko, MD
Listed as a Castle Connolly top doctor of urology
Mark Schoenberg, MD
Listed as a Castle Connolly top doctor of urology
Clinical Trials
Advancing care through clinical trials
Montefiore Einstein Urology participates in both national and clinical trials, a selection of which are highlighted below.
RESTORE: An RCT to Evaluate the Efficacy of the Revi System
The Revi System is indicated for the treatment of patients with symptoms of urgency incontinence alone or in combination with urinary urgency.
Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative
This is a multicenter prospective trial with randomized and observational cohorts assessing patient-reported outcomes and unplanned healthcare utilization following ureteroscopic treatment of renal and ureteral stones, with placement versus omission of a ureteral stent.
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus-Calmette-Guerin
This is a Phase 3, open-label, single arm trial designed to evaluate Cretostimogene patients with NMIBC who have failed prior BCG therapy.
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
This is a Phase 3, open-label, randomized trial designed to evaluate the RFS of TURBT followed by cretostimogene grenadenorepvec versus TURBT followed by observation for the treatment of participants with IR-NMIBC.
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer
This study seeks to determine the clinical impact of Gene Expression Classifier (GEC) testing in prostate cancer care while also developing a pragmatic approach for improved GEC clinical use and future study.
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body.
Patient referrals
At Montefiore Einstein Urology, we know providing patients with the best possible care includes teamwork and trust. We work closely with our valued referring physicians to ensure open communication and reliable expertise.